Profound Medical Corp

About Profound Medical Corp

Profound Medical is a medical technology company focused on providing incision-free ablative interventions for prostate conditions. Their mission is to maintain patients' quality of life while offering customizable, precise, and durable treatments using advanced technologies like real-time MRI imaging.

Products & Services

TULSA-PRO®:A patient-centric solution for prostate ablation, robotically controlled by physicians, using real-time MRI imaging for precise treatment of localized prostate cancer and other prostate conditions. It is CE marked, Health Canada approved, and FDA 510(k) cleared.

Sonalleve®:A technology platform for non-invasive treatments, though specific details are not provided in the content.

Specialties

Transurethral Ultrasound Ablation MRI-Guided Therapies Prostate Cancer Treatment Non-Invasive Medical Procedures

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 6450000 MR: - FA: approximately US$6.45 million FAN: 6450000	D: 2025-12-30 FD: 2025-12-30	-
2	RT: Private Placement T: - FT: Private Placement	A: 6450000 MR: - FA: US$6.45 million FAN: 6450000	D: 2025-12-24 FD: 2025-12-24	-
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 36000000 MR: - FA: approximately $36 million FAN: 36000000	D: 2025-12-23 FD: 2025-12-23	2 investors
4	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 40000000 MR: - FA: up to $40 million FAN: 40000000	D: 2025-12-19 FD: 2025-12-19	2 investors
5	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 40250000 MR: - FA: US$40.25 million FAN: 40250000	D: 2024-12-10 FD: 2024-12-10	4 investors
6	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 35000000 MR: - FA: US$35 million FAN: 35000000	D: 2024-12-06 FD: 2024-12-06	4 investors
7	RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement	A: 2937502 MR: - FA: approximately US$2,937,502 FAN: 2937502	D: 2024-01-16 FD: 2024-01-16	1 investors
8	RT: Public Offering T: - FT: Public Offering	A: 20000000 MR: - FA: US$20,000,000 FAN: 20000000	D: 2023-12-27 FD: 2023-12-27	2 investors

Private Placement Latest

2025-12-30

$6.5M

Private Placement 2025-12-24

$6.5M

Registered Direct Offering 2025-12-23

$36.0M

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Arun Menawat

CEO and Chairman of the Board

T

Tom Tamberrino

Chief Commercial Officer

R

Rashed Dewan

Chief Financial Officer

M

Mathieu Burtnyk

Chief Operating Officer

A

Arthur L. Rosenthal

Director

B

Brian Ellacott

Director

View 16 more team members with Pro

Unlock Full Team Directory

Recent News